About Us
Our History
Company History
After more than 20 years of development, we have provided professional consulting services to more than 1,580 pharmaceutical companies around the world, and are one of the earliest, largest and most influential international consulting firms in the field of compliance consulting in China.
December 1998
CANNY predecessor—Beijing Hongxian Technology Services Co., Ltd.—was established, primarily engaged in consulting services for China's GMP certification and U.S. FDA regulations. This marked China's first professional company dedicated to providing pharmaceutical regulatory compliance consulting.
February 1999
The company began providing GMP consulting services to Chinese pharmaceutical enterprises, with Shanxi Jincheng Pharmaceutical Factory as its first client. That same year, it introduced the European Pharmacopoeia Certificate of Suitability (COS/CEP) application process to China's pharmaceutical industry, becoming the first Chinese company to offer COS/CEP application consulting services domestically. Shandong Lu'an Pharmaceutical became the first client for COS/CEP services, successfully obtaining China's second COS certificate—the first COS certificate applied for and managed by Chinese personnel. (The first COS certificate in China was obtained by a European client on behalf of a supplier in Wuxi, China).
2006
2005
November CANNY entered into a long-term cooperation agreement with Quintiles, primarily focusing on European generic drug registration and U.S. ANDA applications.
October CANNY established a dedicated European registration department for finished pharmaceutical products, initiating regulatory research, personnel training, and collaboration with international consulting firms.
June Hangzhou CANNY co-hosted the third international symposium on “COS Applications, US ANDA Applications, and cGMP Compliance” with the Chinese Pharmaceutical Association and the European Directorate for the Quality of Medicines (EDQM).
2004
November Initiated first collaboration with Quintiles Benefit France, a globally renowned pharmaceutical regulatory compliance consulting firm. Quintiles dispatched a specialist to deliver a keynote presentation titled “Registration of Generic Medicines in Europe” at an international symposium organized by CANNY.
October CANNY co-hosted the second “International Symposium on COS Applications and European Generic Medicine Registration” with the Chinese Pharmaceutical Association and EDQM.
October CANNY established a joint venture with Sano Biotech of the United States, forming Kangnuo International Technology (Beijing) Co., Ltd.
August CANNY executives revisited the U.S. FDA to discuss challenges faced by Chinese pharmaceutical companies in achieving FDA regulatory compliance.
2003
December CANNY assisted the Chinese Pharmaceutical Association in facilitating the EDQM's inaugural international workshop on COS/CEP applications in China (Shanghai).
June CANNY's senior leadership visite d the U.S. Food and Drug Administration (FDA) and the European Directorate for the Quality of Medicines (EDQM), successfully transitioning the company's business model to prioritize both international and Chinese pharmaceutical regulatory compliance.
May During China's inaugural GMP and GSP certification period,CANNY successfully provided certification consulting services to over 100 Chinese pharmaceutical manufacturers and distributors.
September 2000
BEIJING CANNY CONSULTING INC., Ltd. was reorganized and established, with its office located at the National Medical Products Administration Training Center. The company primarily provides China GMP and GSP certification services, as well as regulatory compliance services for pharmaceutical products in Europe and the United States. It became China's first consulting firm of considerable scale with well-established departments and standardized service procedures, offering formal consulting services.
We look forward to more milestones
About Canny
Reliable advisor on pharmaceutical regulations
